# Safety and Efficacy Study of the Amaranth Medical FORTITUDE Bioresorbable Drug-Eluting Coronary Stent

> **NCT02255864** · PHASE2 · UNKNOWN · sponsor: **Amaranth Medical Inc.** · enrollment: 21 (actual)

## Conditions studied

- Coronary Artery Disease
- Myocardial Ischemia

## Interventions

- **DEVICE:** AmM FORTITUDE Bioresorbable Drug-Eluting Coronary Scaffold

## Key facts

- **NCT ID:** NCT02255864
- **Lead sponsor:** Amaranth Medical Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-02
- **Primary completion:** 2016-07
- **Final completion:** 2020-11
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2016-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02255864

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02255864, "Safety and Efficacy Study of the Amaranth Medical FORTITUDE Bioresorbable Drug-Eluting Coronary Stent". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02255864. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*